The fifth Shenzhen International Brand Week opened, and Beike Biotech won two awards!

Brand is an important reflection of the competitiveness of an enterprise and even a country, and is also an important resource for winning the world market. The national “14th Five-Year Plan” and the outline of long-term goals for 2035 propose that manufacturing products should be promoted “Increase varieties, improve quality, and create brands”, carry out Chinese brand creation actions, enhance the influence and competitiveness of independent brands, and cultivate a number of high-end brands. General Secretary Xi Jinping also proposed 700; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;”>”We must promote the transformation from China’s speed to China’s quality, China’s manufacturing to China’s creation, and China’s products to China’s brand”.

On May 11, the 2021 China Brand Day Shenzhen local special activities and the fifth “Shenzhen International Brand Week” event kicked off grandly in the studio of Shenzhen Radio and Television Building; inherit; vertical-align: baseline;”>Beike Biotechnology won the two awards of “Shenzhen Famous Brand” and “Leading Enterprise in China’s Cell Field”. Dr. Hu Junyuan, Chairman of Beike Biotechnology, was invited to receive the award and attend the 2021 Guangdong-Hong Kong-Macao Greater Bay Area Quality Brand Summit Forum. He was invited to attend a roundtable dialogue and discuss brand innovation and breakthrough measures in the digital era with the guests present.

Beike Biotechnology, which has been rooted in the cell field for 16 years, stood out from hundreds of candidate companies with its brand accumulation over the years and won the award. baseline;”>“Shenzhen Famous Brand” and “China’s leading enterprise in the field of cells“ have been recognized in terms of brand strength.

Beike Biotech has a number of experts with outstanding achievements in the field of cells and a professional technical R&D team led by domestic and foreign scholars. We have always insisted on speaking out with professionalism and quality, adhering to the font-weight: 700; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;”>The core corporate philosophy of “loyalty, responsibility, rigor, innovation, care, service, team, and communication” puts corporate innovation capabilities in the first place, continues to deepen product technology research and development capabilities, strictly controls product quality, and has gained popularity and reputation with a rigorous and serious style. It has become The backbone that cannot be ignored in the field of stem cell clinical research in China.

The development of biotechnology is related to the national economy and people’s livelihood, and is also related to the country’s future competitiveness. With the sudden outbreak of the COVID-19 epidemic in 2020, stem cells, especially mesenchymal stem cells (MSC), have shone brightly in research on the treatment of severe and critical illness. Cell therapy technology has ushered in new opportunities for development. Talking about the topic of “How to innovate brands in the digital era”, Dr. Hu Junyuan, chairman of Beike Biotech, was invited to attend the 2021 Guangdong-Hong Kong-Macao Greater Bay Area Quality Brand Summit Forum and attended a roundtable dialogue. He also shared Beike Biotech’s way of breaking through the situation in light of the current situation.